Finally, we observed that BIS I induced the downregulation of many cancer stem genes, CD133 included, and we found that this new marker of EMT is highly regulated as YAP, GSK3β, and β-catenin modulated CD133 expression, addressing this gene as a co-regulated gene by these three factors. This evidence concerns the gene YAP1 and cancer.